{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:13Z","timestamp":1787496853448,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02079-9","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:18:26Z","timestamp":1762424306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endocan levels in patients with hyperprolactinemia"],"prefix":"10.1186","volume":"25","author":[{"given":"Aykut","family":"Hac\u0131\u00f6mero\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u015fk\u0131n","family":"G\u00fcng\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2079_CR1","unstructured":"Thapa S, Bhusal K. Hyperprolactinemia. 2019."},{"issue":"8","key":"2079_CR2","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/en.2006-1577","volume":"148","author":"C Molinari","year":"2007","unstructured":"Molinari C, et al. Prolactin induces regional vasoconstriction through the \u03b22-adrenergic and nitric oxide mechanisms. Endocrinology. 2007;148(8):4080\u201390.","journal-title":"Endocrinology"},{"issue":"4","key":"2079_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0922-4106(92)90110-H","volume":"225","author":"MD Sauro","year":"1992","unstructured":"Sauro MD, Bing B, Zorn NE. Prolactin induces growth-related gene expression in rat aortic smooth muscle in vivo. Eur J Pharmacol Mol Pharmacol. 1992;225(4):351\u20134.","journal-title":"Eur J Pharmacol Mol Pharmacol"},{"issue":"1\u20132","key":"2079_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mce.2005.01.005","volume":"232","author":"AS Goldhar","year":"2005","unstructured":"Goldhar AS, Vonderhaar BK, Trott JF, Hovey RC. Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol Cell Endocrinol. 2005;232(1\u20132):9\u201319.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"2079_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4158\/EP13173.OR","volume":"20","author":"MS Arslan","year":"2014","unstructured":"Arslan MS, et al. Preclinical atherosclerosis in patients with prolactinoma. Endocr Pract. 2014;20(5):447\u201351.","journal-title":"Endocr Pract"},{"key":"2079_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11102-013-0495-z","volume":"17","author":"X-B Jiang","year":"2014","unstructured":"Jiang X-B, et al. Increased carotid intima media thickness is associated with prolactin levels in subjects with untreated prolactinoma: a pilot study. Pituitary. 2014;17:232\u20139.","journal-title":"Pituitary"},{"issue":"8","key":"2079_CR7","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/jcu.23030","volume":"49","author":"D Yazici","year":"2021","unstructured":"Yazici D, Sunbul M, Yasar M, Deyneli O, Yavuz D. Is there an increased cardiovascular risk in patients with prolactinoma? A challenging question. J Clin Ultrasound. 2021;49(8):870\u20137.","journal-title":"J Clin Ultrasound"},{"issue":"1","key":"2079_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/cen.13498","volume":"88","author":"KA Toulis","year":"2018","unstructured":"Toulis KA, et al. Males with prolactinoma are at increased risk of incident cardiovascular disease. Clin Endocrinol. 2018;88(1):71\u20136.","journal-title":"Clin Endocrinol"},{"key":"2079_CR9","doi-asserted-by":"publisher","first-page":"1018090","DOI":"10.3389\/fendo.2022.1018090","volume":"13","author":"A Glezer","year":"2023","unstructured":"Glezer A, Santana MR, Bronstein MD, Donato Jr J, Jallad RS. The interplay between prolactin and cardiovascular disease. Front Endocrinol. 2023;13:1018090.","journal-title":"Front Endocrinol"},{"issue":"11","key":"2079_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/08941939.2020.1792008","volume":"34","author":"P Basim","year":"2021","unstructured":"Basim P, Argun D. A comparison of the Circulating endocan levels between the inflammatory and malignant diseases of the same organ: the breast. J Invest Surg. 2021;34(11):1207\u201313.","journal-title":"J Invest Surg"},{"key":"2079_CR11","doi-asserted-by":"publisher","first-page":"798699","DOI":"10.3389\/fcvm.2021.798699","volume":"8","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Endocan: a key player of cardiovascular disease. Front Cardiovasc Med. 2022;8:798699.","journal-title":"Front Cardiovasc Med"},{"key":"2079_CR12","unstructured":"Klisic A, Kavaric N, Vujcic S, Spasojevic-Kalimanovska V, Ninic A, Kotur-Stevuljevic J. Endocan and advanced oxidation protein products in adult population with hypertension. Eur Rev Med Pharmacol Sci. 2020;24(12)."},{"issue":"1","key":"2079_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23(1):57\u201363.","journal-title":"Diabetes Care"},{"issue":"3","key":"2079_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0002-9378(12)90833-9","volume":"168","author":"Y Okatani","year":"1993","unstructured":"Okatani Y, Sagara Y. Role of melatonin in nocturnal prolactin secretion in women with normoprolactinemia and mild hyperprolactinemia. Am J Obstet Gynecol. 1993;168(3):854\u201361.","journal-title":"Am J Obstet Gynecol"},{"key":"2079_CR15","doi-asserted-by":"crossref","unstructured":"Maiter D. Mild hyperprolactinemia in a couple: what impact on fertility? Annales d\u2019endocrinologie. 2022.","DOI":"10.1016\/j.ando.2022.04.002"},{"issue":"3","key":"2079_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1530\/eje.0.1490187","volume":"149","author":"D Yavuz","year":"2003","unstructured":"Yavuz D, et al. Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women. Eur J Endocrinol. 2003;149(3):187\u201393.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2079_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2265.2006.02469.x","volume":"64","author":"O Serri","year":"2006","unstructured":"Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of Cabergoline therapy. Clin Endocrinol. 2006;64(4):366\u201370.","journal-title":"Clin Endocrinol"},{"key":"2079_CR18","unstructured":"Lin L-Y et al. Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clin Res Cardiol. 2024:1\u201317."},{"key":"2079_CR19","doi-asserted-by":"crossref","unstructured":"Efe MM, Aky\u00fcz A, Ayd\u0131n C, Demirk\u0131ran A, Alpsoy \u015e. Endocan may predict the presence of coronary slow flow and coronary artery disease. Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira. 2024;70(8):e20240515.","DOI":"10.1590\/1806-9282.20240515"},{"issue":"9","key":"2079_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/0003319715625827","volume":"67","author":"T \u00c7imen","year":"2016","unstructured":"\u00c7imen T, et al. Human endothelial cell-specific molecule-1 (endocan) and coronary artery disease and microvascular angina. Angiology. 2016;67(9):846\u201353.","journal-title":"Angiology"},{"issue":"8","key":"2079_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0003319714548870","volume":"66","author":"M Kose","year":"2015","unstructured":"Kose M, et al. Serum endocan level and the severity of coronary artery disease: a pilot study. Angiology. 2015;66(8):727\u201331.","journal-title":"Angiology"},{"issue":"1","key":"2079_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0003319716646932","volume":"68","author":"H Kundi","year":"2017","unstructured":"Kundi H, et al. Admission endocan level May be a useful predictor for in-hospital mortality and coronary severity index in patients with ST-segment elevation myocardial infarction. Angiology. 2017;68(1):46\u201351.","journal-title":"Angiology"},{"issue":"4","key":"2079_CR23","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0003319716651349","volume":"68","author":"C-R Qiu","year":"2017","unstructured":"Qiu C-R, et al. Serum endothelial cell\u2013specific molecule 1 (endocan) levels in patients with acute myocardial infarction and its clinical significance: a pilot study. Angiology. 2017;68(4):354\u20139.","journal-title":"Angiology"},{"key":"2079_CR24","doi-asserted-by":"crossref","unstructured":"Zhao T, et al. The higher serum endocan levels May be a risk factor for the onset of cardiovascular disease: a meta-analysis. Medicine. 2018;97(49):e13407.","DOI":"10.1097\/MD.0000000000013407"},{"issue":"2","key":"2079_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/njcp.njcp_178_20","volume":"24","author":"AO Koca","year":"2021","unstructured":"Koca AO, Da\u011fdeviren M, Akkan T, Keskin M, Pamuk N, Altay M. Is idiopathic mild hyperprolactinemia a cardiovascular risk factor? Niger J Clin Pract. 2021;24(2):213\u20139.","journal-title":"Niger J Clin Pract"},{"issue":"9","key":"2079_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5603\/GP.a2018.0085","volume":"89","author":"IB Delibas","year":"2018","unstructured":"Delibas IB, Yapca OE, Laloglu E. Does endocan level increase in women with polycystic ovary syndrome? A case\u2014control study. Ginekologia Polska. 2018;89(9):500\u20135.","journal-title":"Ginekologia Polska"},{"issue":"4","key":"2079_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.amjmed.2005.10.059","volume":"119","author":"E Carmina","year":"2006","unstructured":"Carmina E, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119(4):356. e351-356. e356.","journal-title":"Am J Med"},{"issue":"10","key":"2079_CR28","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","volume":"103","author":"G Paradisi","year":"2001","unstructured":"Paradisi G, et al. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation. 2001;103(10):1410\u20135.","journal-title":"Circulation"},{"issue":"8","key":"2079_CR29","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0003319715616240","volume":"67","author":"A Icli","year":"2016","unstructured":"Icli A, et al. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology. 2016;67(8):749\u201355.","journal-title":"Angiology"},{"issue":"1","key":"2079_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5114\/amsad.2020.103031","volume":"5","author":"B Boyuk","year":"2020","unstructured":"Boyuk B, Cetin SI, Erman H, Sevinc S, Bulut U, Guzel S. Evaluation of serum endocan levels in relation to epicardial fat tissue thickness in metabolic syndrome patients. Archives Med Science-Atherosclerotic Dis. 2020;5(1):290\u20136.","journal-title":"Archives Med Science-Atherosclerotic Dis"},{"issue":"2","key":"2079_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","volume":"34","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006;34(2):532\u20137.","journal-title":"Crit Care Med"},{"key":"2079_CR32","doi-asserted-by":"crossref","unstructured":"Seo K, Kitazawa T, Yoshino Y, Koga I, Ota Y. Characteristics of serum endocan levels in infection. PLoS ONE. 2015;10(4):e0123358.","DOI":"10.1371\/journal.pone.0123358"},{"issue":"3","key":"2079_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1515\/cclm-2013-0638","volume":"52","author":"S-J Kao","year":"2014","unstructured":"Kao S-J, et al. Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia. Clin Chem Lab Med (CCLM). 2014;52(3):445\u201351.","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"2079_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s12020-013-9931-0","volume":"44","author":"A Atmaca","year":"2013","unstructured":"Atmaca A, Bilgici B, Ecemis GC, Tuncel OK. Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia. Endocrine. 2013;44:756\u201361.","journal-title":"Endocrine"},{"issue":"2","key":"2079_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12020-019-02170-x","volume":"67","author":"AJ Ponce","year":"2020","unstructured":"Ponce AJ, et al. Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine. 2020;67(2):331\u201343.","journal-title":"Endocrine"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02079-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02079-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02079-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:18:30Z","timestamp":1762424310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02079-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2079"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02079-9","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declerations"}},{"value":"The study was performed in line with the principles of the Decleration of Helsinki. Approval was granted by Ethics Committee of The Faculty of Medicine K\u0131r\u0131kkale University before the study began (Decision number 22\/03 on 16th November 2023). The written informed consent has been obtained from the participant involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}